Example: Heart Attack

Search clinical trials for: Nafcillin

Total 14 results

NCT00062647

Completed

Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia

Conditions: Gram-Positive Bacterial Infections
NCT01922011

Completed

Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)

Conditions: Acute Hematogenous Osteomyelitis
NCT02344511

Withdrawn

Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis

Conditions: Osteomyelitis
NCT00711802

Completed

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

Conditions: Skin Diseases, Infectious
NCT01104662

Terminated

Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment

Conditions: Complicated Skin and Skin Structure Infections; S. Aureus Bacteremia; Renal Impairment
NCT03426761

Recruiting

Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Conditions: Bone Infection; Osteomyelitis; Septic Arthritis; Joint Infection; Prosthetic Joint Infection
NCT00428844

Completed

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Conditions: Osteomyelitis
NCT02208063

Terminated

A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

Conditions: Bacteremia
NCT01191840

Completed

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

Conditions: Bacteremia
NCT02099240

Unknown status

Patients Response to Early Switch To Oral:Osteomyelitis Study

Conditions: Osteomyelitis
NCT00077675

Completed

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Conditions: Infections, Gram-positive Bacterial
NCT00061633

Completed

Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Conditions: Infections, Gram-Positive Bacterial; Abscess; Burns; Cellulitis; Ulcer; Wound Infections
NCT01431326

Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Conditions: Adenovirus; Anesthesia; Anxiety; Anxiolysis; Autism; Autistic Disorder; Bacterial Meningitis; Bacterial Septicemia; Benzodiazepine; Bipolar Disorder; Bone and Joint Infections; Central Nervous System Infections; Convulsions; Cytomegalovirus Retinitis; Early-onset Schizophrenia Spectrum Disorders; Epilepsy; General Anesthesia; Gynecologic Infections; Herpes Simplex Virus; Infantile Hemangioma; Infection; Inflammation; Inflammatory Conditions; Intra-abdominal Infections; Lower Respiratory Tract Infections; Migraines; Pain; Pneumonia; Schizophrenia; Sedation; Seizures; Skeletal Muscle Spasms; Skin and Skin-structure Infections; Treatment-resistant Schizophrenia; Urinary Tract Infections; Withdrawal; Sepsis; Gram-negative Infection; Bradycardia; Cardiac Arrest; Cardiac Arrhythmia; Staphylococcal Infections; Nosocomial Pneumonia; Neuromuscular Blockade; Methicillin Resistant Staphylococcus Aureus; Endocarditis; Neutropenia; Headache; Fibrinolytic Bleeding; Pulmonary Arterial Hypertension; CMV Retinitis; Hypertension; Chronic Kidney Diseases; Hyperaldosteronism; Hypokalemia; Heart Failure; Hemophilia; Heavy Menstrual Bleeding; Insomnia
NCT01756924

Terminated

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

Conditions: Prosthetic Joint Infections of Hip; Prosthetic Joint Infections of Knee; Infected Spacers